Atlas Biotech
PrivateLast Round
Pre Seed
Jun 25, 2024
Total Funding Raised
$1.52M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Atlas Biotech is a biotechnology company that provides functional genomics and synthetic biology services, including deep mutational scanning and custom cell line development, to support drug discovery and oncology research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Atlas Biotech Comparables
Compare Atlas Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Heligenics, Inc. | 84% | |
| Ranomics | 79% | |
| Constantiam Biosciences | 78% |
Atlas Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Jun 25, 2024 |
Atlas Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Ben Franklin Technology Partners of Central & Northern PA | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Grew 38% QoQ, from 8 to 11 employees.
- Apr 24, 2026
Monthly visitors grew 1910% MoM, from 52 to 1K.
Atlas Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Atlas Biotech's valuation, stock price, and market status.
Is Atlas Biotech a public or private company?
Atlas Biotech is a private company.
What is the current stock price of Atlas Biotech?
Atlas Biotech is a private company with no public stock price. No recent secondary market data is available.
How much is Atlas Biotech worth (valuation)?
Valuation information for Atlas Biotech is not publicly available.
Can I buy Atlas Biotech stock?
Atlas Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Atlas Biotech's last funding round?
Atlas Biotech's most recent funding round was Pre Seed on June 25, 2024.
Who are the main investors in Atlas Biotech?
Key investors in Atlas Biotech include National Cancer Institute, Ben Franklin Technology Partners of Central & Northern PA.
Will Atlas Biotech IPO soon?
No public IPO plans have been announced for Atlas Biotech.
How can I track Atlas Biotech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Atlas Biotech's secondary market activity and sign up for updates.